Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-20-052110

Chief Financial Officer acquired 331,121 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Alam Kamran Chief Financial Officer 2020-09-23 Grant or award +331,121 331,121 D: show line 1 in the form
Loading xslF345X03/doc4.xml…